The syndrome of
17伪-hydroxylase deficiency is due to the inability to synthesize cortisol and is associated with enhanced secretion of both corticosterone and 11-deoxy-corticosterone (DOC). In humans, corticosterone and its 5伪-Ring A-reduced metabolites are excreted via the bile into the intestine and transformed by anaerobic bacteria to 21-dehydroxylated products: 11
尾-OH-progesterone or 11
尾-OH-(allo)-5伪-preganolones (potent inhibitors of 11
尾-
HSD2 and 11
尾-HSD1 dehydrogenase). Neomycin blocks the formation of these steroid metabolites and can blunt the hypertension in rats induced by either ACTH or corticosterone. 3伪,5伪-Tetrahydro-corticosterone, 11
尾-hydroxy-progesterone, and 3伪,5伪-tetrahydro-11
尾-hydroxy-progesterone strongly inhibit 11
尾-HSD2 and 11
尾-HSD1 dehydrogenase activity; all these compounds are hypertensinogenic when infused in adrenally intact rats.
Urine obtained from a patient with 17伪-hydroxylase deficiency demonstrated markedly elevated levels of endogenous glycyrrhetinic acid-like factors (GALFs) that inhibit 11尾-HSD2 and 11尾-HSD1 dehydrogenase activity (>300 times greater, and >400 times greater, respectively, than those in normotensive controls). Thus, in addition to DOC, corticosterone and its 5伪-pathway products as well as the 11-oxygenated progesterone derivatives may play a previously unrecognized role in the increased Na+ retention and BP associated with patients with 17伪-hydroxylase deficiency.